Significantly, five of these genes (Mvd, Sqle, Cyp51, Hsd17b7, and Dhcr24) are within the core biochemical processes of the mevalonate pathway, an important target for anti-cancer therapy [24, 27]. Here, DHCR24 is linked to cancer.